Combined oral contraceptive use reduces the risk of ovarian cancer by 40% and the risk of endometrial cancer by 50% compared to never users.
Combined oral contraceptive use lowers ovarian cancer by 40% and endometrial cancer by 50% compared to people who do not use it.